Industry News
Pharmaceutical Industry News
Cold Chain Technologies is…
Cold Chain Technologies is eliminating 82 positions at its headquarters in Franklin, Massachusetts, according to a state Worker Adjustment and Retraining Act (WARN) report. The company said it is shifting some of its operations from
“At the FDA’s request, Dr….
“At the FDA’s request, Dr. Vinay Prasad is resuming leadership of the Center for Biologics Evaluation and Research,” an HHS spokesperson told Fierce Pharma.
Will MAHA Change America?
The outsider critique of the medical establishment has always struggled to offer an alternative vision that’s rigorous rather than credulous.
Why Are Tariffs on Switzerland So High?
President Trump sees Switzerland as doing too little to address its trade deficit with the U.S., a gap he focused on as he imposed a 39% tariff on Swiss goods.
While most of Gilead’s…
While most of Gilead’s second-quarter presentation focused on its excitement over the launch of game-changing HIV PrEP drug Yeztugo, there was a disquieting sidebar as sales of its cell therapies were down by 7%.
“Free Mind” is the first…
“Free Mind” is the first public health campaign launched by the CDC since Robert F. Kennedy Jr. was appointed secretary of the U.S. Department of Health and Human Services.
After telegraphing an…
After telegraphing an investigation in November, the FDA has moved to restrict the use of bluebird bio’s gene therapy Skysona in certain CALD patients.
Pfizer and BioNTech have settled…
Pfizer and BioNTech have settled an mRNA patent lawsuit originally brought by CureVac in the U.S. The deal will see BioNTech pay out cash and extend royalties from sales of its COVID vaccine to CureVac
Sanofi is pulling its PCSK9 drug…
Sanofi is pulling its PCSK9 drug Praluent from the Chinese market. President Donald Trump said U.S. pharmaceutical tariffs may eventually reach 250%. A venture capital crunch in Southeast Asia is pushing investors to be more
Genmab and AbbVie have presented…
Genmab and AbbVie have presented new data that could help grow the reach of their blood cancer drug Epkinly in follicular lymphoma. The partners are anticipating a November 30 FDA decision date to move an
In line with the Trump…
In line with the Trump administration’s goal to curb the U.S.’ reliance on overseas drug manufacturing, the FDA has deployed a new program designed to take some of the headache out of setting up domestic
Only a few months after stepping…
Only a few months after stepping into the role of senior VP of marketing and patient solutions for U.S. operations at Novo Nordisk, Ulrich Otte is no longer in the position, a company spokesperson confirmed
How Ozempic Maker Novo Nordisk Lost Its Shine
The pioneering Danish drugmaker was once the most valuable company in Europe, but analysts say a number of missteps reversed its fortunes.
A federal court of appeals judge…
A federal court of appeals judge upheld a lower court's decision to dismiss a lawsuit challenging the constitutionality of the drug price negotiation program.
Pill Causes Major Weight Loss in Eli Lilly Trial’s Results
The company said it planned to seek Food and Drug Administration approval for the drug, orforglipron, before the end of the year.
CorMedix is expanding its…
CorMedix is expanding its portfolio of infectious disease products for hospitalized patients with the acquisition of another New Jersey-based commercial-stage company, Melinta Therapeutics, for $300 million.
As the Trump administration seeks…
As the Trump administration seeks to align U.S. drug prices with lower reference costs in places like Europe, Eli Lilly’s CEO has cautioned that flaws in the American healthcare system, which “isn’t built to function
65% of HCP digital interactions…
65% of HCP digital interactions lead nowhere. Learn 5 customer journey orchestration tactics to transform static pharma websites into dynamic experiences.
Four Key Facts About Trump’s New Tariffs, and a Town Hall Showdown
Plus, inside the weight-loss drug wars.
The FDA has removed a pause in the…
The FDA has removed a pause in the use of Valneva’s chikungunya vaccine in older adults while tweaking the shot’s label with stricter language.